Armistice Capital Performance Showcases Strategic Shift in Neuromuscular Research Investment
The investment landscape in neuromuscular disorder treatments has gained significant momentum, driven by a pressing need for therapeutic solutions in a field where current options remain limited. Industry analysis indicates that among the more than 30 identified neuromuscular diseases, many still lack adequate treatment options, with existing medications often producing significant side effects. Market projections […]